Literature DB >> 22826832

A combined index of structure and function for staging glaucomatous damage.

Felipe A Medeiros1, Renato Lisboa, Robert N Weinreb, Christopher A Girkin, Jeffrey M Liebmann, Linda M Zangwill.   

Abstract

OBJECTIVES: To present and evaluate a new combined index of structure and function (CSFI) for staging and detecting glaucomatous damage.
METHODS: Observational study including 333 glaucomatous eyes (295 with perimetric glaucoma and 38 with preperimetric glaucoma) and 330 eyes of healthy subjects.All the eyes were tested with standard automated perimetry and spectral domain optical coherence tomography within 6 months. Estimates of the number of retinal ganglion cells (RGCs) were obtained from standard automated perimetry and spectral domain optical coherence tomography and a weighted averaging scheme was used to obtain a final estimate of the number of RGCs for each eye. The CSFI was calculated as the percent loss of RGCs obtained by subtracting estimated from expected RGC numbers. The performance of the CSFI for discriminating glaucoma from normal eyes and the different stages of disease was evaluated by receiver operating characteristic curves.
RESULTS: The mean CSFI, representing the mean estimated percent loss of RGCs, was 41% and 17% in theperimetric and preperimetric groups, respectively(P.001). They were both significantly higher than the mean CSFI in the healthy group (P.001). The CSFI had larger receiver operating characteristic curve areas than isolated indexes of structure and function for detecting perimetric and preperimetric glaucoma and differentiating among early, moderate, and advanced stages of visual field loss.
CONCLUSION: An index combining structure and function performed better than isolated structural and functional measures for detection of perimetric and preperimetric glaucoma as well as for discriminating different stages of the disease.

Entities:  

Mesh:

Year:  2012        PMID: 22826832

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  18 in total

1.  Regional correlation among ganglion cell complex, nerve fiber layer, and visual field loss in glaucoma.

Authors:  Phuc V Le; Ou Tan; Vikas Chopra; Brian A Francis; Omar Ragab; Rohit Varma; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-21       Impact factor: 4.799

2.  The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change.

Authors:  Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Kaweh Mansouri; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

3.  [Flicker and conventional perimetry in comparison with structural changes in glaucoma].

Authors:  F Dannheim
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

4.  OCT Circle Scans Can Be Used to Study Many Eyes with Advanced Glaucoma.

Authors:  Seung H Lee; Devon B Joiner; Emmanouil Tsamis; Rashmi Rajshekhar; Eleanor Kim; C Gustavo De Moraes; Robert Ritch; Donald C Hood
Journal:  Ophthalmol Glaucoma       Date:  2019-02-12

5.  Longitudinal Macular Structure-Function Relationships in Glaucoma and Their Sources of Variability.

Authors:  Kouros Nouri-Mahdavi; Nima Fatehi; Joseph Caprioli
Journal:  Am J Ophthalmol       Date:  2019-05-10       Impact factor: 5.258

6.  Four Questions for Every Clinician Diagnosing and Monitoring Glaucoma.

Authors:  Donald C Hood; Carlos G De Moraes
Journal:  J Glaucoma       Date:  2018-08       Impact factor: 2.503

7.  Incorporating risk factors to improve the assessment of rates of glaucomatous progression.

Authors:  Felipe A Medeiros; Linda M Zangwill; Kaweh Mansouri; Renato Lisboa; Ali Tafreshi; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

8.  Estimating the rate of retinal ganglion cell loss in glaucoma.

Authors:  Felipe A Medeiros; Linda M Zangwill; Douglas R Anderson; Jeffrey M Liebmann; Christopher A Girkin; Ronald S Harwerth; Marie-Josée Fredette; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2012-07-27       Impact factor: 5.258

Review 9.  Combining structure and function to evaluate glaucomatous progression: implications for the design of clinical trials.

Authors:  Renato Lisboa; Robert N Weinreb; Felipe A Medeiros
Journal:  Curr Opin Pharmacol       Date:  2012-12-04       Impact factor: 5.547

10.  Predicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts.

Authors:  Daniel Meira-Freitas; Renato Lisboa; Andrew Tatham; Linda M Zangwill; Robert N Weinreb; Christopher A Girkin; Jeffrey M Liebmann; Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.